摘要
胰淀素(amylin)亦称胰岛淀粉样多肽(islet amyloid polypeptide,IAPP),发现于1987年,由CarthCooper等在英国剑桥大学从2型糖尿病病人的胰腺中提取出来,并报道了其全部氨基酸序列。胰淀紊是同胰岛素一起由胰岛B细胞分泌的一种多肽,属神经内分泌激素,与糖尿病关系密切,在骨代谢方面也起着重要作用。一直以来,糖尿病所引起的大血管、微血管并发症很受关注,而骨质疏松对糖尿病患者的影响通常不受重视。由糖尿病所引起的继发性骨质疏松症可以给糖尿病患者的健康造成严重的威胁,并且将给社会和家庭带来沉重的经济负担。迄今为止,
出处
《中国医师进修杂志(内科版)》
2006年第3期74-75,77,共3页
Chinese Journal of Postgraduates of Medicine
参考文献20
-
1Bronsky J, Chada M, Kotaska K, et al. Amylin - its physiological role in humans. Cesk Fysiol, 2002, 51(4):176- 180.
-
2Chau DL, Edelman SV, Chandran M. Osteoporosis and Diabetes.Curr Diab Rep, 2003, 3(1): 37-42.
-
3陆邦超,孟萍.胰淀素与骨代谢[J].国外医学(内分泌学分册),2002,22(4):229-231. 被引量:2
-
4Wimalawansa SJ. Amylin, calcitonin gene- related peptide, calcitonin, and adrenomedullin: a peptide superfamily. Crit Rev Neurobiol, 1997,11 ( 2 - 3) : 167 - 239.
-
5戴芳,倪安民.胰淀素、胰岛淀粉样蛋白沉积与2型糖尿病[J].国外医学(内分泌学分册),2001,21(3):125-127. 被引量:3
-
6Jhamandas JH, Mac Tavish D. Antagonist of the amylin receptor blocks beta- amyloid toxicity in rat cholinergic basal forebrain neurons. J Neurosci, 2004, 24(24):5579-5584.
-
7Cueille C, Garel JM. RAMPs and G protein coupled receptors. Med Sol(Pairs), 2004,20(8 - 9) : 773 - 778.
-
8Wimalawansa SJ. Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: a peptide superfamily. Crit Rev Neurobiol, 1997,11 (2 - 3) : 167 - 239.
-
9Hull RL, Westermark GT, Westermark P, et al. Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J Clin Endoerinol Metab, 2004, 89(8) :3629 - 3643.
-
10Lopes DH, Colin C, Degaki TL. Amyloidogenicity and cytotoxicity of recombinant mature human islet amyloid polypeptide (rhlAPP).J Biol Chem, 2004, 279(41):42803-42810.
二级参考文献15
-
1Wimalawansa S J. Amylin, calcitonin gene-related peptide,calcitonin, and adrenomedullin : a peptide superfamily [J].Crit Rev Neurobiol, 1997,11:167-239.
-
2Vine W, Beaumont K, Gedulin B, et al. Comparison of the in vitro and in vivo pharmacology of adrenomedullin calcitonin gene-related peptide and amylin in rats[J]. Eur J Pharmacol, 1996,314:115-121.
-
3Burns M D, Kawase T. Calcitonin gene-related peptide,amylin, or parathyroid hormone stimulate (in vitro) biomineralization(Abstract) [J]. J Bone Miner Res, 1997,12:324-326.
-
4Cornish J, Callon K E, Lin C Q, et al. Comparison of the effects of calcitonin gene-related peptide and amylin on osteoblasts[J]. J Bone Miner Res, 1999,14:1302-1309.
-
5Shih C, Bernard G W. Calcitonin gene related peptide enhances bone colony development in vitro [J]. Clin Orthop,1997,334: 335-344.
-
6Villa I, Rubinacci A, Ravasi F, et al. Effects of amylin on human osteoblast-like cells [J]. Peptides, 1997, 18: 537-540.
-
7Villa I, Melzi R, Pagani F, et al. Effects of ealcitonin generelated peptide and amylin on human osteoblast-like cells proliferation [J]. Eur J Pharmacol, 2000,409: 273-278.
-
8Cornish J, Callon K E, Bava U, et al. Effects of calcitonin, amylin, and calcitonin gene-related peptide on oste-oclast development [J]. Bone, 2001,29: 162-168.
-
9Cornish J, Callon K E, Lin C Q, et al. Dissociation of the effects of amylin on osteoblast proliferation and bone resorption[J]. Am J Physiol, 1998,274(5 Pt 1): E827-E833.
-
10Cornish J, Callon K E, Gasser J A, et al. Systemic administration of a novel octapeptide, amylinl-8 , increases bone volume in male mice [J]. Am J Physiol Endocrinol Metab,2000,279: E730-E735.
同被引文献21
-
1徐立群,张荣华,蔡宇,黄丰,朱晓峰,杨丽,傅淑平.糖尿病骨质疏松症中医病机和治则探讨[J].四川中医,2005,23(2):27-28. 被引量:10
-
2卢明,赵莉娟.糖尿病骨质疏松症的发病机理及影响因素研究进展[J].山西中医学院学报,2010,11(4):73-75. 被引量:17
-
3郭宝荣,杨文军,张珊珊,李英杰.益肾壮骨合剂治疗老年糖尿病合并骨质疏松症临床研究[J].山东中医杂志,2006,25(3):157-158. 被引量:14
-
4向志雄,黄诚,彭新君,秦莹.中药治疗糖尿病及其并发症研究进展[J].中西医结合学报,2006,4(3):321-325. 被引量:23
-
5徐磊,苏玲.滋肾通络胶囊治疗糖尿病骨质疏松症疗效观察[J].辽宁中医杂志,2006,33(8):960-961. 被引量:7
-
6钟丽娜,李长贵,苗志敏.糖尿病性骨质疏松的研究进展[J].医学综述,2007,13(3):219-221. 被引量:21
-
7石存英.绝经期骨质疏松症知识女性精神、心理行为特征分析[J].中国医师进修杂志,2007,30(2):54-55. 被引量:3
-
8美国糖尿病协会(ADA)第2003 年63 届年会.国外医学内分泌学分册,2003,23(5):293-358.
-
9Eidtmann H,De Boer R,Bundred N,et al.Efficacy of zoledronic acid inpostmenopausal women with early breast cancer receiving adjuvant letrozole:36-monthresults of the ZO-FAST study[J].Ann Oncol,2010,21(11):2188-2194.
-
10Black DM,Delmas PD,Eastell R,et al.Once-yearly zoledronic acid for treatmentof postmenopausal osteoporosis[J].N Engl J Med,2007,356:1809-1822.
二级引证文献8
-
1钱语,王旭.糖尿病性骨质疏松症的中医药治疗进展[J].现代中西医结合杂志,2011,20(13):1682-1683. 被引量:7
-
2杨真,侯建明.糖尿病合并骨质疏松症的中西医治疗进展[J].中医临床研究,2013,5(1):119-120. 被引量:16
-
3巩振东,李翠娟,王琳.糖尿病性骨质疏松症中医药治疗研究进展[J].陕西中医学院学报,2015,38(6):136-139. 被引量:3
-
4曹灵修,张林.补泻兼施防治糖尿病骨质疏松症的可行性探讨[J].江西中医药,2016,47(9):15-17. 被引量:10
-
5袁丽娟.唑来膦酸注射液治疗糖尿病合并骨质疏松效果分析[J].当代医学,2019,25(1):66-67. 被引量:3
-
6曹灵修,任路,张林.中医药防治糖尿病骨质疏松症研究概述[J].山东中医杂志,2020,39(5):525-529. 被引量:9
-
7程建,蔡建平,吴晓东,华臻,王磊,刘明明.糖尿病并发骨质疏松症的中医临床经验[J].现代中西医结合杂志,2020,29(23):2619-2622. 被引量:9
-
8王雨辰,芮立宁,贾川,俞伟忠.强骨合剂通过Wnt3a/β-catenin/VEGF信号通路促进血管生成改善围绝经期大鼠骨质疏松的研究[J].南京中医药大学学报,2022,38(9):819-826. 被引量:6
-
1朱哲宇,郭晓东,夏芊,康怡,邹日坤.老年慢性阻塞性肺疾病与继发性骨质疏松症的相关性分析[J].现代生物医学进展,2013,13(9):1736-1738. 被引量:1
-
2张金红.中西医结合治疗2型糖尿病合并骨质疏松症疗效观察[J].现代中西医结合杂志,2016,25(25):2797-2800. 被引量:3
-
3何斌.中医辨证论治老年糖尿病并发骨质疏松症40例[J].福建中医药,2013,44(6):43-43. 被引量:8
-
4陈旭民.COPD患者血清瘦素、骨密度与中医分型的关系[J].浙江中西医结合杂志,2011,21(5):325-326. 被引量:2
-
5张洪德,胡远峰.胰岛淀粉样多肽与Ⅱ型糖尿病的关系[J].上海医学,1993,16(7):430-432. 被引量:1
-
6朱铁虹.胰岛淀粉样多肽与糖尿病[J].国外医学(内分泌学分册),1994,14(4):178-180. 被引量:1
-
7顾明君,钟学礼.胰岛淀粉样多肽研究进展[J].中华内分泌代谢杂志,1991,7(4):231-234. 被引量:2
-
8张国英,郭宁,黄建伟,陈蕴清,刘君,刘群,张卫平.2型糖尿病患者血浆胰淀素水平变化的临床研究[J].天津医药,2004,32(2):117-117. 被引量:5
-
9张鑫,程彪,黄昆.胰岛淀粉样多肽的研究进展[J].生命科学,2010,22(6):567-574. 被引量:5
-
10申露(译).脂蛋白(α)是冠心病发生的独立风险因素[J].中华医学信息导报,2008,23(15):7-7.